RNA sequences of cochlear hair cells after ibrutinib treatment

These findings confirm ibrutinib’s ototoxicity and highlight the protective role of GPR83 in ibrutinib-induced hearing loss, supporting future clinical investigations into Z-VAD-FMK and GPR83 as interventions for ibrutinibor other chemotherapeuticdrug-induced ototoxicity.